Pay in 4 interest-free payments of $7.19 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
We highlight the role of novel therapies distinct from the gutkidney axis, including non-steroidal mineralocorticoid receptor antagonists (nsMRAs)
doi: 10.1016/j.micres.2023.127517 435 VitielloA.FerraraF.BoccellinoM.PonzoA.CimminoC.ComberiatiE.et al
Experimenters should set up the corresponding parameters in the software, including the animals number, date, and status light information
This work was supported by the National Institute on Drug Abuse Intramural Research Program (M.F., G.R.M., M.N.N., V.M., O.A.A., M.A.H., and L.L.) and the National Institute on Alcohol Abuse and Alcoholism Division of Intramural Clinical and Biological Research (M.F., G.R.M., V.M., and L.L.)
